← Back to Clinical Trials
Recruiting NCT04897347

NCT04897347 Robotic TruST-Postural Intervention for Children With Cerebral Palsy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04897347
Status Recruiting
Phase
Sponsor Teachers College, Columbia University
Condition Cerebral Palsy
Study Type INTERVENTIONAL
Enrollment 82 participants
Start Date 2022-02-26
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 6 Years
Max Age 17 Years
Study Type INTERVENTIONAL
Interventions
Robotic Trunk-Support-Trainer (TruST)Static Trunk Support

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 82 participants in total. It began in 2022-02-26 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to test the efficacy of a motor learning-based postural and reaching control intervention delivered with the robotic Trunk-Support-Trainer (TruST) compared to the same motor learning-based intervention delivered with Static Trunk Support Equipment in children with cerebral palsy (CP) classified as III and IV with the Gross Motor Function Classification System (GMFCS).

Eligibility Criteria

Inclusion Criteria: * Age 6-17 years * Diagnosis of Bilateral CP: diplegia, triplegia, or quadriplegia * Gross Motor Function Classification Systems-Expanded \& Review (GMFCS) levels III or IV * Ability to sit 5s with trunk support between mid-ribs and pelvis (SATCo = 3-7) * Cognitive capacity to follow basic verbal instructions (i.e., "do not put your hands on your lap" or "follow and reach the toy") Exclusion Criteria: * Absent head control (SATCo = 1) * Current medical illness unrelated to CP at the time of the study * Severe dyskinesia that prevents the child from maintaining sitting and recovering balance during reaching movements * History of recurrent seizures (daily) or drug-resistance epilepsy * Severe Spinal Deformities: scoliosis \>40◦ and/or kyphosis \>45◦ * Spinal osteosynthesis or orthopedic surgery of spine, upper or lower extremities in the last 6 months * Severe spasticity of biceps/triceps in both upper extremities (Modified Ashworth Scale = 4) * Local chemodenervation therapy in spastic muscles (e.g., botulinum toxin or phenol injections) in upper or lower extremities in the previous 3 months or planned during the study * Other major surgeries in the previous 6 months (if medically contraindicated)

Contact & Investigator

Central Contact

Victor Santamaria, PT, PhD

✉ vs2578@columbia.edu

📞 212.678.3332

Principal Investigator

Sunil Agrawal, PhD

PRINCIPAL INVESTIGATOR

Columbia University

Frequently Asked Questions

Who can join the NCT04897347 clinical trial?

This trial is open to participants of all sexes, aged 6 Years or older, up to 17 Years, studying Cerebral Palsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04897347 currently recruiting?

Yes, NCT04897347 is actively recruiting participants. Contact the research team at vs2578@columbia.edu for enrollment information.

Where is the NCT04897347 trial being conducted?

This trial is being conducted at New York, United States, New York, United States.

Who is sponsoring the NCT04897347 clinical trial?

NCT04897347 is sponsored by Teachers College, Columbia University. The principal investigator is Sunil Agrawal, PhD at Columbia University. The trial plans to enroll 82 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology